Cost-Effectiveness of Ultrasound-Guided Corticosteroid Injection for Hip Osteoarthritis
Author Information
Author(s): Kigozi Jesse, Oppong Raymond, Paskins Zoe, Bromley Kieran, Lewis Martyn, Hughes Gemma, Hughes Emily, Hennings Susie, Cherrington Andrea, Hall Alison, Holden Melanie A, Stevenson Kay, Menon Ajit, Roberts Philip, Peat George, Jinks Clare, Foster Nadine E, Mallen Christian D, Roddy Edward
Primary Institution: Institute of Applied Health Research, University of Birmingham
Hypothesis
Is adding an ultrasound-guided corticosteroid injection to best current treatment cost-effective for hip osteoarthritis?
Conclusion
Adding an ultrasound-guided corticosteroid injection to best current treatment for hip osteoarthritis results in lower costs and better outcomes.
Supporting Evidence
- BCT+US-T was associated with lower mean NHS costs and higher mean QALYs than BCT alone.
- Participants receiving BCT+US-T had fewer visits to NHS consultants and private physiotherapists.
- Days off work were significantly lower in the BCT+US-T group compared to the BCT group.
- BCT+US-T dominated BCT alone in terms of cost-effectiveness.
- Health-related quality of life improved more in the BCT+US-T group than in the BCT group.
Takeaway
Giving a special injection along with advice helps people with hip pain feel better and costs less money.
Methodology
A trial-based cost–utility analysis comparing best current treatment with and without ultrasound-guided injections over 6 months.
Potential Biases
Potential inaccuracies in self-reported resource use and work-related data.
Limitations
Self-reported data may lead to inaccuracies, and findings may not be generalizable to other settings.
Participant Demographics
Participants aged ≥40 years with moderate–severe hip pain, recruited from NHS services.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% CI: −£583.95, £54.18
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website